ArticleEndocrine connections2026
German law on protection of children with DSD: first data on care after enactment.
Article in Endocrine connections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In May 2021, a German law was implemented to protect children with differences of sex development (DSD) from non-consensual genital surgery. In children and persons incapable of giving consent, exceptions can occur in emergencies or with the approval of the family court. To this end, a favourable opinion from an interdisciplinary DSD committee can be submitted to initiate file-based court proceedings. This study analysed the frequency of referrals post-legislation, alongside diagnoses and demographic information. Methods: A survey by the German Society for Paediatric and Adolescent Endocrinology and Diabetology identified centres with interdisciplinary committees. Data from these centres were analysed descriptively. Results: Ten centres established interdisciplinary committees, evaluating 78 patients. The common karyotypes were 46,XX (36%) and 46,XY (55%), with other variations at 9%. The median age at initial presentation was 0.91 years, with most evaluations happening in surgical departments (80.8%). In 46,XX individuals, CAH due to 21-hydroxylase deficiency (21OHD) was predominant (93%), with a median Prader score of 4. In 46,XY individuals, phenotypic assessments mostly identified various levels of undervirilisation, mainly proximal hypospadias. Conclusion: This study highlights the significant impact of this legislation on clinical practice for DSD in Germany. Our results show that the majority of patients with DSD assessed by the interdisciplinary committee had a diagnosis of CAH or hypospadias. The composition of the interdisciplinary committee is prescribed by law, but the approach to counselling may vary depending on the discussions within the DSD committee. Open questions include reimbursement and evaluation criteria. Plain language summary: In 2021, Germany introduced a law to protect children with a difference of sex development who are not yet able to give their own consent. We investigated how often specialist teams were asked by families to provide an opinion to facilitate surgery, and the changes in care that have resulted from the law. Most of the children had CAH or hypospadias.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.